EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glycosylation in kidney diseases

Yingying Ling, Fei Cai, Tao Su, Yi Zhong, Ling Li, Bo Meng, Guisen Li, Meng Gong, Hao Yang iD, Xinfang Xie, Zhenyu Sun, Yang Zhao und 2 weitere

Precision Clinical Medicine · 28.06.2025 · 8 (3)

DOI: 10.1093/pcmedi/pbaf017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 11.07.2025. Verfasst von Yingying Ling und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichu…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 301 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein glycosylation is a critical post-translational modification that influences protein folding, localization, stability, and functional interactions by attaching glycans to specific sites. This process is crucial for biological functions of glycoproteins, and aberrant glycosylation can lead to genetic disorders, immune system issues, and multi-organ pathologies. Recent advancements in glycoproteomic technologies have made the study of protein glycosylation a key focus for understanding the pathogenesis of kidney diseases. This review provides a comprehensive overview of protein glycosylation mechanisms, its biological roles, molecular pathways, and significant functions in renal physiology and pathology. It specifically highlights the dynamic changes and regulatory networks associated with aberrant glycosylation in kidney diseases such as immunoglobulin A nephropathy, diabetic kidney disease, autosomal dominant polycystic kidney disease, renal cell carcinoma, and acute kidney injury. It also evaluates the clinical applications of related technologies and biomarkers. Additionally, it discusses the challenges in developing glycosylation-targeted therapeutic strategies. Future research should focus on clarifying cell-specific glycosylation regulatory networks in the kidney, integrating glycobiology with multi-omics approaches, and improving precision diagnostics and treatment for kidney diseases.

Schlagwörter

Stichwörter der Autor:innen

biomarkersglycoproteomicsglycosylationkidney diseasesmass spectrometry

Autor:innen und Institutionen

  • Department of Nephrology, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Technology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
  • Renal Department and Institute of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Sichuan Clinical Research Center for Kidney Diseases, Chengdu 611731, China.
  • Transplant Center and NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Nephrology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.

ORCID-Profile: Hao Yang, Yong Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Ling, Y., Cai, F., Su, T., Zhong, Y., Li, L., Meng, B., Li, G., Gong, M., Yang, H., Xie, X., Sun, Z., Zhao, Y., Liu, F., & Zhang, Y. (2025). Glycosylation in kidney diseases. Precision Clinical Medicine, 8(3). https://doi.org/10.1093/pcmedi/pbaf017

Vancouver

Ling Y, Cai F, Su T, Zhong Y, Li L, Meng B, et al. Glycosylation in kidney diseases. Precision Clinical Medicine. 2025;8(3). doi:10.1093/pcmedi/pbaf017

BibTeX
@article{Ling2025,
  author = {Ling, Yingying and Cai, Fei and Su, Tao and Zhong, Yi and Li, Ling and Meng, Bo and Li, Guisen and Gong, Meng and Yang, Hao and Xie, Xinfang and Sun, Zhenyu and Zhao, Yang and Liu, Fang and Zhang, Yong},
  title = {Glycosylation in kidney diseases},
  journal = {Precision Clinical Medicine},
  year = {2025},
  volume = {8},
  number = {3},
  doi = {10.1093/pcmedi/pbaf017}
}
Kostenlos starten →